| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/23/2007 | US20070197514 Conjugates with organic acids; uses thereof in the treatment of psychotic and/or proliferative disorders and diseases and as chemosensitizing agents; the organic acids are selected to reduce side effects induced by the psychotropic drugs and/or to exert an anti-proliferative activity |
| 08/23/2007 | US20070197501 Use Of Chemotherapeutic Agents |
| 08/23/2007 | US20070197468 Oral formulations of cladribine |
| 08/23/2007 | US20070197465 Hyaluronic Acid-Methotrexate Conjugate |
| 08/23/2007 | US20070197428 Novel indications of mannan-binding lectin (MBL) in the treatment of immuno-compromised individuals |
| 08/23/2007 | US20070197427 O,o'-amidomalonate and n,o-amidomalonate platinum complexes |
| 08/23/2007 | US20070196505 Compositions and Methods for Improving Skin Health and Pelage Quality |
| 08/23/2007 | US20070196504 Pharmaceutical composition |
| 08/23/2007 | US20070196500 Composition for oral administration of tamsulosin hydrochloride and controlled release granule formulation comprising same |
| 08/23/2007 | US20070196499 Residual Solvent extraction method and microparticles produced thereby |
| 08/23/2007 | US20070196497 Pharmaceutical formulations for the prolonged release of active principle(s) and their applications |
| 08/23/2007 | US20070196495 Method for administering medicaments to subjects with swallowing difficulties and disorders |
| 08/23/2007 | US20070196489 Taste masked pharmaceutical particles |
| 08/23/2007 | US20070196484 Poorly water-soluble drug-containing solid formulation |
| 08/23/2007 | US20070196481 Sustained-release tablet composition |
| 08/23/2007 | US20070196480 Sustained release formulation for oral administration of hmg-coa reductase inhibitor and method for the preparation thereof |
| 08/23/2007 | US20070196478 Antiviral compositions |
| 08/23/2007 | US20070196464 Bioavailability; absorption; using fatty acid, or salt thereof, or fatty ester |
| 08/23/2007 | US20070196460 External preparation for treating skin or mucosal injury caused by viral infection |
| 08/23/2007 | US20070196455 Crosslinkable pressure-sensitive adhesive for skin |
| 08/23/2007 | US20070196446 Conjugated fatty acid esters |
| 08/23/2007 | US20070196445 Method for the Prevention and Treatment of Cachexia and Anorexia |
| 08/23/2007 | US20070196444 Pantoprazole multiparticulate formulations |
| 08/23/2007 | US20070196443 Spherical core with enteric overcoating; antiulcer agents |
| 08/23/2007 | US20070196442 Method for improving the oral administration of alpha-lipoic acid |
| 08/23/2007 | US20070196440 Treatment methods requiring phyto-ingredients |
| 08/23/2007 | US20070196439 Lactose-reduced dairy compositions and related methods |
| 08/23/2007 | US20070196438 Compositions for the treatment of osteoarthritis and to nourish the synovial fluid |
| 08/23/2007 | US20070196437 Slowly digesting starch and fermentable fiber |
| 08/23/2007 | US20070196436 Process for preparing an edible composition comprising steroidal glycosides |
| 08/23/2007 | US20070196435 Drug and food or drink for improving hyperglycemia |
| 08/23/2007 | US20070196426 Biocompatible crosslinked gel |
| 08/23/2007 | US20070196425 Thermosensitive and biodegradable microgel and a method for the preparation thereof |
| 08/23/2007 | US20070196417 Therapeutic polyanhydride compounds for drug delivery |
| 08/23/2007 | US20070196391 Mucosal boosting following parenteral priming |
| 08/23/2007 | US20070196385 Method of treating hepatitis C infection |
| 08/23/2007 | US20070196366 Methods for treating cancer using an immunotoxin |
| 08/23/2007 | US20070196332 Cytotoxic agents comprising taxanes and their therapeutic use |
| 08/23/2007 | US20070196331 Methods and compositions for mobilizing stem cells |
| 08/23/2007 | US20070196288 Method of treating periodontitis and of reducing dentinal sensitivity |
| 08/23/2007 | US20070196286 Aerosol composition comprising formoterol |
| 08/23/2007 | US20070196284 Micelles associated to outer surface of liposome envelope by electrostatic interaction; active compound incorporated into the micelles linking a large amount of active compound to a single liposome carrier; bioavailability; image-enhanced contrast agents for imaging (MRI); tissue-targeted therapy |
| 08/23/2007 | US20070196283 Composition for transfection of DNA into the liver |
| 08/23/2007 | US20070196281 Method and articles for remote magnetically induced treatment of cancer and other diseases, and method for operating such article |
| 08/23/2007 | US20070196275 Diagnostic Imaging Compositions, Their Methods Of Synthesis And Use |
| 08/23/2007 | CA2642847A1 Dissolution aids for oral peptide delivery comprising a biguanide |
| 08/23/2007 | CA2642248A1 Accelerating agent of calcium absorption |
| 08/23/2007 | CA2642241A1 New stable hyperbaric composition comprising prilocaine hcl, use of said new composition for intrathecal anaesthesia, and method for manufacturing said composition |
| 08/23/2007 | CA2641616A1 Pharmaceutical formulations |
| 08/23/2007 | CA2641605A1 Pharmaceutical formulations |
| 08/23/2007 | CA2641604A1 Pharmaceutical formulations |
| 08/23/2007 | CA2641342A1 Long-acting polypeptides and methods of producing and administering same |
| 08/23/2007 | CA2641116A1 Aqueous pharmaceutical formulations of er.beta. selective ligands |
| 08/23/2007 | CA2638907A1 Rage fusion proteins and methods of use |
| 08/23/2007 | CA2556305A1 Rapidly dissolving solid oral dosage form for delivery of composition for increasing nitric oxide activity |
| 08/22/2007 | EP1820516A2 Novel albumin-free factor VIII formulations |
| 08/22/2007 | EP1820501A1 Therapeutic agent for depletion of an unwanted protein population from plasma |
| 08/22/2007 | EP1820499A1 Green algal extract containing astaxanthin having high storage stability |
| 08/22/2007 | EP1820497A2 Effervescent bisphosphonate formulation |
| 08/22/2007 | EP1820495A2 Microspheres for active embolization |
| 08/22/2007 | EP1819723A2 Drug delivery peptides for crossing blood-brain barrier |
| 08/22/2007 | EP1819363A2 Method for the production of albumen conjugates with non-steroidal antirheumatic drugs (nsar) |
| 08/22/2007 | EP1819362A2 Topical nepafenac formulations |
| 08/22/2007 | EP1819359A2 Anti-integrin immunoconjugates, methods and uses |
| 08/22/2007 | EP1819345A2 Use of lipid conjugates in the treatment of disease |
| 08/22/2007 | EP1819297A2 Uv cured gel and method of making |
| 08/22/2007 | EP1819230A2 Cell-derived microparticles as hemostatic agents for control of hemorrhage and treatment of bleeding disorders |
| 08/22/2007 | EP1819227A1 Pharmaceutical formulation of decitabine |
| 08/22/2007 | EP1495075B1 Solid emulsions based on thermoplastic elastomers |
| 08/22/2007 | EP1476470B1 Starch derivatives, starch active substance conjugates, method for the production thereof and their use as medicaments |
| 08/22/2007 | EP1379513B1 Prodrugs of cox-2 inhibitors |
| 08/22/2007 | EP1351673B1 Compositions of stable t3 and use thereof |
| 08/22/2007 | EP1333851B1 Selfemulsifiable formulation having enhanced bioabsorption and immunosuppression activities |
| 08/22/2007 | EP1303292A4 Chemokine conjugates |
| 08/22/2007 | EP1242009B1 Tissue sensitizing compounds for females with methods and apparatus for the delivery of these compounds |
| 08/22/2007 | EP1052975B1 Propofol composition containing sulfite |
| 08/22/2007 | EP0935631B1 Grafted rubber-like silicone gel with enhanced oil compatibility and its synthetic process |
| 08/22/2007 | EP0794798B1 Compositions of nucleic acid and viscosity-increasing polymer pvp for use in gene therapy |
| 08/22/2007 | EP0773950B1 Linked peptide nucleic acids |
| 08/22/2007 | EP0715856B1 Keratin-storable antifungal composition for external use |
| 08/22/2007 | CN1332946C Premedicine acting on nervous centralis system |
| 08/22/2007 | CN1332716C High molecular antineoplastic cisplatin medicine and preparation method thereof |
| 08/22/2007 | CN1332711C Method for administering GLP-1 molecules |
| 08/22/2007 | CN1332665C Nicotine-containing film preparation |
| 08/22/2007 | CN1332658C Antibacterial compositions comprising metal phthalocyanine analogues |
| 08/22/2007 | CN1332655C Uses of targeted oxidative therapeutic formulation in arteriosclerosis |
| 08/22/2007 | CN1332648C Microemulsion preconcentrate |
| 08/22/2007 | CN101023164A Cancerous disease modifying antibodies |
| 08/22/2007 | CN101023119A Novel block copolymer, micelle preparation, and anticancer agent containing the same as active ingredient |
| 08/22/2007 | CN101022835A Cyanine dyes conjugated with antibodies for the diagnosis of micrometastasis |
| 08/22/2007 | CN101022833A Use of glycerol dipalmitostearate for improving the bioavailability of protein active ingredients in subcutaneous or intramuscular injectable formulations |
| 08/22/2007 | CN101022832A Composition for promoting vascular smooth muscle relaxation |
| 08/22/2007 | CN101022822A Liquid preparation of physiologically active peptide |
| 08/22/2007 | CN101022785A External preparation of s/o type |
| 08/22/2007 | CN101022784A Infusion and injection solution of levodopa |
| 08/22/2007 | CN101020782A Prepn process of nanometer particle of poly (amide-amine)-poly (L-benzyl-glutamate) |
| 08/22/2007 | CN101020067A Transdermal plaster prepn for 99m TC methylene diphosphonate |
| 08/22/2007 | CN101020062A Hydrophilic polyglycol supported ursolic acid medicines and their prepn process |
| 08/22/2007 | CN101020061A Prepn process of ultrasonically controlled releasing micro gel containing medicine |
| 08/22/2007 | CN101020060A Cyclodextrin clathrate of entecavir and its prepn proces and medicinal application |